Aduhelm (aducanumab-avwa) (Intravenous) Coverage Criteria
Customize your policy alerts
Sign up for Capital Bluecross Policy IC-0610NC alerts
Get alerted when Policy IC-0610NC changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and prior authorization for Aduhelm (aducanumab-avwa) intravenous treatment and states the payer's stance on its medical necessity for Alzheimer's disease and related indications.
No material clinical or coverage changes in this revision.
Coverage Determination
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.